Analyst firms · Piper Sandler · AMPH
Piper Sandler AMPH price target and rating history
Amphastar Pharmaceuticals Inc. (AMPH) · Health Care
Piper Sandler rates Amphastar Pharmaceuticals Inc. (AMPH) Neutral with a $36 price target, as of its latest action on Feb 4, 2025. It has published 3 rating actions on AMPH since January 2022, including 1 upgrade and 1 downgrade. Across 4 firms with a AMPH price target in the last 12 months, the median target is $21.
- Current rating
- Neutral
- Price target
- $36
- Median target, all firms
- $21
- Actions on AMPH
- 3
Piper Sandler price target on AMPH
Every Piper Sandler rating on AMPH
- Feb 4, 2025
- Mar 11, 2022
- Jan 7, 2022
How other firms rate AMPH
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Underperform | $20 | Jun 29, 2026 |
| Wells Fargo | Equal Weight | $19 | May 14, 2026 |
| Needham | Hold | May 8, 2026 | |
| Jefferies | Hold | $22 | Apr 21, 2026 |
| Barclays | Equal Weight | $30 | Dec 9, 2025 |
Questions about Piper Sandler and AMPH
- What is Piper Sandler's price target for AMPH?
- Piper Sandler's latest stated price target for Amphastar Pharmaceuticals Inc. (AMPH) is $36, from its action on Feb 4, 2025.
- What is Piper Sandler's rating on AMPH?
- Piper Sandler rates AMPH Neutral, a neutral rating, as of Feb 4, 2025.
- When did Piper Sandler last change its view on AMPH?
- On Feb 4, 2025, Piper Sandler downgrades to Neutral from Overweight, price target $66 to $36.
- How does Piper Sandler's AMPH target compare with other analysts?
- Across 4 firms with a AMPH price target in the last 12 months, the median target is $21.
More AMPH rating histories
All Piper Sandler ratingsAMPH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.